Data for review in connection with the New Drug Application to NAFDAC for use as an immune booster and adjunct treatment for Human Immunodeficiency Virus ORLANDO, FL AND DUBLIN, IRELAND / ACCESSWIRE / IMUN/ January 21, 2016 / Immune Therapeutics Inc., a U.S. public company (OTCQB: IMUN) today announced that it has completed its 90-day bridging trail of Human Immunodeficiency Virus positive [HIV+] patients and submitted data to The National Agency for Food and Drug Administration and Control, (NAFDAC) inRead more
- Alternate Health Launches First Complete Ethereum Blockchain EMR / EHR
- NutraFuels, Inc. (NTFU) Provides 2017 Year End Financials Revenues Increase 694.6%
- Genprex Joins The Health Discovery Building At Dell Medical School To Help Drive Innovation For Health And Life Sciences
- Cannabics Pharmaceuticals Announces New Technology Patent
- Trump Cannabis Statements Leads Sugarmade to Positively Modify Business Growth Plans
SMALL CAP MARKET NEWS
We release small market news updates daily, 5 times a week! Always check back to get the inside scoop on what going on.
LEVERAGE OUR MASSIVE INVESTOR AUDIENCE!
Stock Investors · Accredited Investors · Hedge Fund InvestorsLearn More